Sign inJoin waitlistJoin the waitlist

AO

Alexander Olawaiye

Vice Chair of Diversity and Community Engagement · Univ of Pittsburgh Sch of Med

Credentials: · · · · · ·

History

Diversity and Community Engagement · Univ of Pittsburgh Sch of Med
Present
Univ of Pittsburgh Sch of Med
Present
Director of Clinical Research for Gynecologic Oncology · University at Buffalo School of Medicine
Present

Obstetrics and Gynecology
University at Buffalo School of Medicine
2000–2004
Harvard Medical School
1987–1991

Research

Revised FIGO staging for carcinoma of the cervix uteri
Review · International Journal of Gynecology & Obstetrics · 2019 · 755 citations
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
Journal of Clinical Oncology · 2016 · 306 citations
Endometrial cancer: a review and current management strategies: part I
Review · Gynecologic Oncology · 2014 · 288 citations

Paniti Sukumvanich
54 papers
Sushil Beriwal
46 papers
Robert Edwards
45 papers
JK
Joseph Kelley
36 papers
Madeleine Courtney-Brooks
34 papers · 12 as a fellow
JB
Jessica Berger
31 papers · 3 as a fellow
ST
Sarah Taylor
28 papers
JC
John Comerci
24 papers
Michelle Boisen
23 papers · 7 as a resident
Thomas Krivak
19 papers
JL
Jamie Lesnock
16 papers · 1 as a fellow
JV
John Vargo
16 papers · 5 as a resident

Grants

HCC Ovarian Cancer SPORE
National Cancer Institute · P50
Project lead · $813K · University of Pittsburgh at Pittsburgh
2023–2028

Clinical trials

Upfront Maintenance Olaparib in Advanced Ovarian Cancer BRCAwt Patients With Known Homologous Recombination Deficiency
Principal investigator · Withdrawn · Phase 2
Alexander B Olawaiye, MD
2024–2029
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
Principal investigator · Recruiting · Phase 2
Alexander B Olawaiye, MD
2023–2034
Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer
Principal investigator · Active not recruiting · Phase 2
Alexander B Olawaiye, MD
2023–2029
T-regulatory Cell Depletion With E7777 Combined With Pembrolizumab in Recurrent or Metastatic Solid Tumors
Principal investigator · Active not recruiting · Phase 1, Phase 2
Alexander B Olawaiye, MD
2022–2030